The arranged marriage of cangrelor and bivalirudin

JACC Cardiovasc Interv. 2015 Mar;8(3):434-435. doi: 10.1016/j.jcin.2015.01.004. Epub 2015 Feb 18.

Authors

Gilles Montalescot¹, Gérard Helft²

Affiliations

¹ ACTION Study Group, Institut de Cardiologie (AP-HP), Hôpital Pitié-Salpêtrière, University Paris 6, INSERM UMRS 1166, Paris, France. Electronic address: gilles.montalescot@psl.aphp.fr.
² ACTION Study Group, Institut de Cardiologie (AP-HP), Hôpital Pitié-Salpêtrière, University Paris 6, INSERM UMRS 1166, Paris, France.

PMID: 25703891
DOI: 10.1016/j.jcin.2015.01.004

No abstract available

Keywords: P2Y(12) antagonists; anticoagulation; antiplatelet therapy; percutaneous coronary intervention; stent thrombosis.

Publication types

Editorial
Comment

MeSH terms

Adenosine Monophosphate / analogs & derivatives*
Anticoagulants / therapeutic use*
Coronary Artery Disease / therapy*
Female
Humans
Male
Peptide Fragments / therapeutic use*
Percutaneous Coronary Intervention*
Platelet Aggregation Inhibitors / therapeutic use*
Ticlopidine / analogs & derivatives*

Substances

Anticoagulants
Peptide Fragments
Platelet Aggregation Inhibitors
Adenosine Monophosphate
Ticlopidine